awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47349992-12B04094-7821-44F6-8717-4E05B243E2A1
Q47349992-12B04094-7821-44F6-8717-4E05B243E2A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47349992-12B04094-7821-44F6-8717-4E05B243E2A1
Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.
P2860
Q47349992-12B04094-7821-44F6-8717-4E05B243E2A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47349992-12B04094-7821-44F6-8717-4E05B243E2A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51b62d7c399a5b263c77911962cbc8501afd2d05
P2860
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.